GENTRACK GROUP LIMITED (GTK)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

GTK

GTK - GENTRACK GROUP LIMITED

FNArena Sector : Software & Services
Year End: September
GICS Industry Group : Software & Services
Debt/EBITDA: 0.56
Index: ASX300 | ALL-ORDS | ALL-TECH

LAST PRICE CHANGE +/- CHANGE % VOLUME

$10.73

27 May
2025

0.060

OPEN

$10.50

0.56%

HIGH

$10.76

219,799

LOW

$10.49

TARGET
$12.833 19.6% upside
Franking for last dividend paid out: 9%
OTHER COMPANIES IN THE SAME SECTOR
360 . AHI . ALC . AMX . ATA . BMT . COS . DOC . EVS . KYP . NET . NXL . QOR . RDY . SKO . UBN . VGL . XF1 . YOJ .
FNARENA'S MARKET CONSENSUS FORECASTS
GTK: 1
Title FY25
Forecast		 FY26
Forecast
EPS (cps) 13.1 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 81.7 xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 06/12 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx8.5
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx196.6 M
Book Value Per Share xxxxxxxxxxxxxxx184.2
Net Operating Cash Flow xxxxxxxxxxxxxxx32.4 M
Net Profit Margin xxxxxxxxxxxxxxx4.48 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx4.90 %
Return on Invested Capital xxxxxxxxxxxxxxx4.55 %
Return on Assets xxxxxxxxxxxxxxx3.55 %
Return on Equity xxxxxxxxxxxxxxx4.90 %
Return on Total Capital xxxxxxxxxxxxxxx10.01 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx31.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxxxxx13 M
Total Debt xxxxxxxxxxxxxxx16 M
Goodwill - Gross xxxxxxxxxxxxxxx103 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx61 M
Price To Book Value xxxxxxxxxxxxxxx5.35

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx1.0 M
Capex % of Sales xxxxxxxxxxxxxxx0.51 %
Cost of Goods Sold xxxxxxxxxxxxxxx147 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx30 M
Research & Development xxxxxxxxxxxxxxx21 M
Investments - Total xxxxxxxxxxxxxxx11 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

20/05/2025

3

Upgrade to Neutral from Sell

-

-

UBS raises its target price for Gentrack Group to NZ$12.00 from NZ$11.75 and upgrades to Neutral from Sell.

The broker acknowledges 1H earnings were softer than expected, due to project revenue lumpiness and increased investment in utilities R&D and sales, but highlights an "impressive" pipeline.

The company reported revenue of NZ$112m and earnings (EBITDA) of NZ$13m, which was -15% below UBS and consensus. Airport earnings exceeded expectations, and a stronger New Zealand dollar added a 7% earnings tailwind, explains the broker.

The broker expects FY25 to be a transitional year as management expands into Asia, the Middle East and Europe.

Management is guiding to revenue of greater than or equal to NZ$230m and earnings margins above 12%, implying to UBS earnings of at least NZ$29m, -15% below consensus.

UBS believes growth will resume in FY26 as international scoping studies convert to longer-term contracts. 

FORECAST
UBS forecasts a full year FY25 dividend of 0.00 cents and EPS of 14.59 cents.
UBS forecasts a full year FY26 dividend of 0.00 cents and EPS of 24.62 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

5

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Moelis

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Wilsons

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Canaccord Genuity

22/05/2025

1

Buy

-

-

Canaccord Genuity has made no change to its Buy rating or NZ$14.50 price target for Gentrack Group post the release of interim financials.

Revenue and EBITDA forecasts for FY25–FY27 have been revised lower, with EBITDA reduced by -2% to -6% across the forecast period.

The broker notes the result featured a short-term step-down in non-recurring revenue, but strong recurring revenue growth of 17% yoy and ARR of NZ$76m (4% better than forecast) were a positive surprise.

Management re-iterated confidence in its (more than) 15% CAGR mid-term revenue target, with pipeline momentum expected to lift in FY26-FY27, supported by high sales activity in Asia, the Middle East and Europe.

Despite a -9% share price reaction, the analysts believe the downgrade cycle has ended and the longer-term valuation remains attractive

FORECAST
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 27.08 cents.
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 28.45 cents.

Jarden

xx/xx/xxxx

4

xxxxxxxxxxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

xx/xx/xxxx

1

xxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Extra Coverage Research History >

GTK STOCK CHART

FNArena News on GTK

1
Weekly Ratings, Targets, Forecast Changes – 23-05-25

May 26 2025 - Weekly Reports
2
FNArena Corporate Results Monitor – 23-05-2025

May 23 2025 - Australia
3
Australian Broker Call *Extra* Edition – May 22, 2025

May 22 2025 - Daily Market Reports
4
Gentrack Stumbles, But Confidence Remains High

May 21 2025 - Small Caps
5
Australian Broker Call *Extra* Edition – May 20, 2025

May 20 2025 - Daily Market Reports

Latest Software & Services News

1
Rudi’s View: How Do We Value The Future?

May 28 2025 - Rudi's View
2
TechnologyOne: The ‘Beat’ Goes On

May 23 2025 - Australia
3
AI Investments Fuel Australia’s Data Centre Future

May 22 2025 - Feature Stories
4
Gentrack Stumbles, But Confidence Remains High

May 21 2025 - Small Caps
5
Xero: Maximising Long-Term Value Creation

May 20 2025 - Australia
6
Records Abound For Life360

May 14 2025 - Australia
7
DUG Technology’s Multiple Growth Levers

May 09 2025 - Small Caps
8
Positive Trend Reversal For NextDC

Apr 29 2025 - Technicals
9
Technology One Shares Aiming For A Breakout

Apr 15 2025 - Technicals
10
Megaport’s Quest Of Data Centre Agnostic Growth

Apr 03 2025 - Small Caps